Moderna to Present at Upcoming Conferences in September 2026

Rhea-AI Summary

Moderna (Nasdaq:MRNA) will participate in two investor events in September 2026: the Morgan Stanley 24th Annual Global Healthcare Conference on September 14 at 10:00 a.m. ET, and the Bernstein Insights: Healthcare Leaders and Disruptors 3rd Annual Healthcare Forum on September 23 at 8:50 a.m. ET.

Live webcasts and 30-day replays of both presentations will be accessible under “Events and Presentations” in the Investors section of Moderna’s website.

Market Context

Historical event INTerpath-001 provided a company-specific reference point for evaluating this confe...

Analysis

Historical event INTerpath-001 provided a company-specific reference point for evaluating this conference schedule. The platform record also showed Net Selling insider sentiment and moderate short positioning, factors to watch alongside future disclosures.

Key Figures

Morgan Stanley conference date: September 14, 10:00 a.m. ET Bernstein forum date: September 23, 8:50 a.m. ET Webcast replay period: at least 30 days +2 more

5 metrics

Morgan Stanley conference date September 14, 10:00 a.m. ET 24th Annual Global Healthcare Conference

Bernstein forum date September 23, 8:50 a.m. ET 3rd Annual Healthcare Forum

Webcast replay period at least 30 days Following each presentation

Morgan Stanley conference number 24th Annual Global Healthcare Conference

Bernstein forum number 3rd Annual Healthcare Forum

Historical Context

5 past events · Latest: Aug 28 (Negative)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 28	Convertible notes offering	Negative	-3.4%	Priced upsized convertible notes offering; market reaction was negative over 24 hours.
Aug 27	FDA approval	Positive	-4.6%	FDA approved updated 2026–2027 COVID-19 vaccines for specified populations.
Aug 27	Convertible notes placement	Negative	-4.6%	Proposed $2.0 billion convertible senior notes private placement preceded negative reaction.
Aug 19	Phase 3 clinical data	Positive	+177.0%	INTerpath-001 met recurrence-free and distant metastasis-free survival endpoints.
Aug 05	FDA approval	Positive	-4.3%	FDA fully approved mFLUSIVA for adults 50 years and older.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Positive announcements did not consistently align: both FDA approval events diverged, while the Phase 3 clinical result aligned; financing reactions aligned negatively.

Key Terms

mrna

1 terms

mrna technical

"Moderna is a pioneer and leader in the field of mRNA medicine."

mRNA, short for messenger ribonucleic acid, is a biological molecule that carries instructions from a cell’s genetic blueprint to make specific proteins — like a recipe or software code that tells a kitchen or computer what to produce. Investors care because mRNA is used as a flexible drug and vaccine platform that can be developed and scaled faster than many traditional medicines; its commercial prospects, manufacturing needs, regulatory approval path, and patent position can strongly affect a company’s value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, MA / ACCESS Newswire / September 1, 2026 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:

• Morgan Stanley 24^th Annual Global Healthcare Conference, on Monday, September 14 at 10:00 a.m. ET

• Bernstein Insights: Healthcare Leaders and Disruptors 3^rd Annual Healthcare Forum, on Wednesday, September 23 at 8:50 a.m. ET

A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com.

A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.

About Moderna

Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.

With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.

Investors:

Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View the original press release on ACCESS Newswire

FAQ

When will Moderna (MRNA) present at the Morgan Stanley Global Healthcare Conference in September 2026?

Moderna will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026, at 10:00 a.m. ET. According to Moderna, investors can access the live webcast via the Investors section of its website.

What time is Moderna’s presentation at the Bernstein Healthcare Leaders and Disruptors Forum in September 2026?

Moderna is scheduled to present at the Bernstein Insights: Healthcare Leaders and Disruptors 3rd Annual Healthcare Forum on Wednesday, September 23, 2026, at 8:50 a.m. ET. According to Moderna, the session will be available through a live webcast online.

How can investors access the live webcasts of Moderna’s September 2026 conferences (MRNA)?

Investors can access live webcasts of both September 2026 presentations in the “Events and Presentations” section of Moderna’s Investors website. According to Moderna, each event will be streamed online at investors.modernatx.com.

Will replays of Moderna’s September 2026 conference presentations be available to MRNA investors?

Yes, replays of each September 2026 webcast will be archived on Moderna’s website for at least 30 days. According to Moderna, investors can revisit the presentations via the Investors section after the live events.

Where can I find more investor information about Moderna (MRNA) around its September 2026 conferences?

Investor information is available on Moderna’s website, particularly in the Investors section at investors.modernatx.com. According to Moderna, this area hosts events, presentations, and archived webcasts related to its investor communications.